Wikipedia
NeuVax
NeuVax is a peptide vaccine aimed at preventing or delaying the recurrence of breast cancer in cancer survivors who achieve remission after standard of care treatment (e.g., surgery, radiation, chemotherapy). The product's developer is the US biotechnology company Galena Biopharma.